コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 as identified recently as a receptor for the hepatitis A virus.
2 ths were Salmonella Typhi, Taenia solium and hepatitis A virus.
3 fectively prevented with vaccination against hepatitis A virus.
4 rent infection as the community reservoir of hepatitis A virus.
5 e genome is conserved among strains, such as hepatitis A virus.
6 solate, respectively, of the HM175 strain of hepatitis A virus.
7 the parameters for the ubiquitination of the hepatitis A virus 3C protease are K(m) = 20 +/- 5 microm
9 we amplified virtually the entire genomes of hepatitis A virus (a member of the Picornaviridae family
11 and genetic depletion studies, we show that hepatitis A virus, an hepatotropic picornavirus, broadly
12 andomization, 1414 (31%) were susceptible to hepatitis A virus and 1090 were eligible for the per-pro
14 multiple human maladies, yet currently, only hepatitis A virus and poliovirus can be controlled with
15 ad through the oral-fecal route (salmonella, hepatitis A virus), and organisms spread through direct
16 , Chlamydia pneumoniae, Helicobacter pylori, hepatitis A virus, and herpes simplex virus-1 were measu
19 f passively transferred maternal antibody to hepatitis A virus (anti-HAV) on the duration of seroposi
21 es of the encephalomyocarditis virus and the hepatitis A virus are both type III substrates for the m
22 rhinovirus, encephalomyocarditis virus, and hepatitis A virus) are morphologically similar, comprisi
23 enteric viruses, such as Human Norovirus and Hepatitis A Virus, are readily transmitted via the fecal
25 cally linked to asthma and is a receptor for hepatitis A virus, but the endogenous ligand of TIM-1 is
26 an KIM-1 exhibits homology to a monkey gene, hepatitis A virus cell receptor 1 (HAVcr-1), which was i
28 lar injury [KIM-1 (kidney injury molecule-1)/Hepatitis A virus cellular receptor 1 ( Havcr1)] were ev
31 e toxin binds to protein receptors including hepatitis A virus cellular receptor 1 (HAVCR1), but the
33 expression of the inhibitory receptors PD-1, hepatitis A virus cellular receptor 2 (TIM3), lymphocyte
34 in-containing protein 3 (TIM3, also known as hepatitis A virus cellular receptor 2), and their respec
35 e disease in countries with very low and low hepatitis A virus endemicity, and universal childhood va
36 munized sequentially with tetanus toxoid and hepatitis A virus failed to develop antibody to either a
40 dministered to persons after exposure to the hepatitis A virus has not been compared directly with im
42 Vaccination provides long-term immunity to hepatitis A virus (HAV) among the general population, bu
43 lages in rural Alaska between 2 epidemics of hepatitis A virus (HAV) and after the second epidemic (1
44 ess the protective 190/4 epitope, they bound hepatitis A virus (HAV) and gained limited susceptibilit
45 ZCCHC14 is an essential host factor for both hepatitis A virus (HAV) and hepatitis B virus (HBV).
47 a child who died of FVH upon infection with hepatitis A virus (HAV) at age 11 yr and who was homozyg
48 irus B3, human rhinovirus 14, mengovirus, or hepatitis A virus (HAV) capsid proteins were supplied in
52 s (eHAV) are infectious and the only form of hepatitis A virus (HAV) found circulating in blood durin
57 deoxynojirimycin] inhibit the replication of hepatitis A virus (HAV) in cell culture (50% inhibitory
59 r highly specific and sensitive detection of hepatitis A virus (HAV) in food and water are of particu
65 on has dramatically reduced the incidence of hepatitis A virus (HAV) infection, but new infections co
66 n of HEV infection has broad similarities to hepatitis A virus (HAV) infection, with most cases being
79 the high-risk groups for vaccination against hepatitis A virus (HAV) is unlikely to have a significan
85 A common cause of acute hepatitis in humans, hepatitis A virus (HAV) replicates within hepatocytes wi
86 unclear whether NK cells are elevated due to hepatitis A virus (HAV) replication and ongoing associat
87 apy for hepatitis A, and many aspects of the hepatitis A virus (HAV) replication cycle remain to be e
88 and accurate molecular diagnostic tools for hepatitis A virus (HAV) RNA detection, subgenotype ident
95 lonal antibody (MAb) 190/4 blocks binding of hepatitis A virus (HAV) to the HAV cellular receptor 1 (
96 tion between homelessness and infection with hepatitis A virus (HAV) using a test-negative study desi
97 l responses (Seroresponse) and durability of hepatitis A virus (HAV) vaccination are reduced among hu
98 or Disease Control and Prevention recommends hepatitis A virus (HAV) vaccination for all children at
101 ve no serological responses to their primary hepatitis A virus (HAV) vaccination or have seroreversio
102 h men (MSM) receiving two and three doses of hepatitis A virus (HAV) vaccine and HIV-uninfected MSM r
103 the safety and immunogenicity of 2 doses of hepatitis A virus (HAV) vaccine followed by a booster do
106 ' nontranslated region in the replication of hepatitis A virus (HAV) was studied by analyzing the tra
107 uman (HM-175) and simian (AGM-27) strains of hepatitis A virus (HAV) were constructed to evaluate the
108 tream of the internal ribosome entry site of Hepatitis A virus (HAV) were studied, a 35mer (HAV-35),
112 of positive-strand RNA viruses that includes hepatitis A virus (HAV), an ancient human pathogen that
114 ed immunization for hepatitis B virus (HBV), hepatitis A virus (HAV), and COVID-19 during natalizumab
115 s known about the mechanism of cell entry of hepatitis A virus (HAV), and the identification of cellu
116 on, all participants were vaccinated against hepatitis A virus (HAV), and the increase of antibody ti
117 Many 'non-enveloped' viruses, including hepatitis A virus (HAV), are released non-lytically from
119 ition caused by hepatotropic viruses such as hepatitis A virus (HAV), hepatitis B virus (HBV), and HS
120 IgG antibodies to cytomegalovirus (CMV), hepatitis A virus (HAV), herpes simplex virus type 1 (HS
121 'NTR) of an attenuated, cell culture-adapted hepatitis A virus (HAV), HM175/P16, enhance growth in cu
122 d States was surveyed for antibody titers to hepatitis A virus (HAV), measles virus (MeV), and cytome
124 ad outbreaks of person-to-person transmitted hepatitis A virus (HAV), particularly among people who i
126 y a stem-loop structure with cre function in hepatitis A virus (HAV), the type species of this genus,
129 (HepA) vaccination recommendations in 2006, hepatitis A virus (HAV)-associated outbreaks have increa
130 rticipate in cargo delivery from exosomes of hepatitis A virus (HAV)-infected cells (exo-HAV) by clat
137 udies show that some picornaviruses, notably hepatitis A virus (HAV; genus Hepatovirus) and some memb
138 respond to a recall antigen and neoantigen (hepatitis A virus [HAV] vaccine) after 3 vaccinations.
140 chimpanzee sera; sera from chimpanzees with hepatitis A virus, hepatitis B virus, or hepatitis C vir
143 Mutations which positively affect growth of hepatitis A virus in cell culture may negatively affect
144 uring serial passage of the HM-175 strain of hepatitis A virus in MRC-5 cell cultures in order to det
146 itis B virus now joins hepatitis C virus and hepatitis A virus in targeting the same innate immune re
147 ibility to immunoinflammatory conditions and hepatitis A virus-induced liver failure, which is though
148 der had a significantly higher prevalence of hepatitis A virus infection (37%) than children living i
150 ica, DRB1*1301 is associated with protracted hepatitis A virus infection which may enhance exposure t
151 NK cells respond during the early stages of hepatitis A virus infection, we generated mice that are
153 84- angstrom resolution crystal structure of hepatitis A virus IRES domain V (dV) in complex with a s
154 passively transferred maternal antibodies to hepatitis A virus (maternal anti-HAV) may lower the infa
155 l bacteria in the gastrointestinal tract and hepatitis A virus, may normally induce the development o
156 erved as controls, with infections by either hepatitis A virus or hepatitis B virus (HBV), or a nonin
157 tion from transcripts containing the IRES of hepatitis A virus or hepatitis C virus in BS-C-1 cells a
158 s community was largely spared from a recent hepatitis A virus outbreak in San Diego, California.
159 that the heterogeneous mixture of infectious hepatitis A virus particles (virions and provirions) typ
162 ing information, and did genetic analysis of hepatitis A virus recovered from patients' serum and sto
165 ad elevated titers of antibody to H. pylori, hepatitis A virus, rotavirus, and malaria at the outset,
166 unoglobulins A (IgA), G (IgG), and M (IgM)], hepatitis A virus, rotavirus, tetanus toxoid (IgG), and
167 ce (55% vs 55%) for patients with cirrhosis, hepatitis A virus screening (69% vs 56%), hepatitis C vi
168 patitis A (HepA) vaccine was assessed in 133 hepatitis A virus-seronegative, human immunodeficiency v
170 idence interval: 0.8, 2.9) of H. pylori with hepatitis A virus seroprevalence that weakened after adj
171 tion since proteins of hepatitis C virus and hepatitis A virus similarly bind IPS-1 and target it for
173 lace, and postexposure prophylaxis with both hepatitis A virus vaccine and immunoglobulin was provide
174 to 18 years of age) to receive MenB-FHbp or hepatitis A virus vaccine and saline and assigned 3304 y
177 trial phase, after which participants in the hepatitis A virus vaccine control group were provided th